Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 39

1.

Correction to: Pediatric Insulin Injection Technique: A Multi-Country Survey and Clinical Practice Implications.

Kalra S, Hirsch LJ, Frid A, Deeb A, Strauss KW.

Diabetes Ther. 2018 Dec;9(6):2303. doi: 10.1007/s13300-018-0528-8.

2.

Pediatric Insulin Injection Technique: A Multi-Country Survey and Clinical Practice Implications.

Kalra S, Hirsch LJ, Frid A, Deeb A, Strauss KW.

Diabetes Ther. 2018 Dec;9(6):2291-2302. doi: 10.1007/s13300-018-0514-1. Epub 2018 Sep 21. Erratum in: Diabetes Ther. 2018 Oct 29;:.

3.

Preventing contrast medium-induced acute kidney injury : Side-by-side comparison of Swedish-ESUR guidelines.

Nyman U, Ahlkvist J, Aspelin P, Brismar T, Frid A, Hellström M, Liss P, Sterner G, Leander P; Contrast Media Committee of the Swedish Society of Uroradiology and in collaboration with the Swedish Society of Nephrology (GS) and the Swedish Society of Diabetology (AF).

Eur Radiol. 2018 Dec;28(12):5384-5395. doi: 10.1007/s00330-018-5678-6. Epub 2018 Aug 21.

PMID:
30132106
5.

Effect of Oral Pre-Meal Administration of Betaglucans on Glycaemic Control and Variability in Subjects with Type 1 Diabetes.

Frid A, Tura A, Pacini G, Ridderstråle M.

Nutrients. 2017 Sep 12;9(9). pii: E1004. doi: 10.3390/nu9091004.

6.

Liraglutide and Renal Outcomes in Type 2 Diabetes.

Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators.

N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011.

7.

Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.

Lind M, Polonsky W, Hirsch IB, Heise T, Bolinder J, Dahlqvist S, Schwarz E, Ólafsdóttir AF, Frid A, Wedel H, Ahlén E, Nyström T, Hellman J.

JAMA. 2017 Jan 24;317(4):379-387. doi: 10.1001/jama.2016.19976. Erratum in: JAMA. 2017 May 9;317(18):1912.

PMID:
28118454
8.

New Insulin Delivery Recommendations.

Frid AH, Kreugel G, Grassi G, Halimi S, Hicks D, Hirsch LJ, Smith MJ, Wellhoener R, Bode BW, Hirsch IB, Kalra S, Ji L, Strauss KW.

Mayo Clin Proc. 2016 Sep;91(9):1231-55. doi: 10.1016/j.mayocp.2016.06.010. Review.

9.

Worldwide Injection Technique Questionnaire Study: Injecting Complications and the Role of the Professional.

Frid AH, Hirsch LJ, Menchior AR, Morel DR, Strauss KW.

Mayo Clin Proc. 2016 Sep;91(9):1224-30. doi: 10.1016/j.mayocp.2016.06.012. Review.

10.

Worldwide Injection Technique Questionnaire Study: Population Parameters and Injection Practices.

Frid AH, Hirsch LJ, Menchior AR, Morel DR, Strauss KW.

Mayo Clin Proc. 2016 Sep;91(9):1212-23. doi: 10.1016/j.mayocp.2016.06.011. Review.

11.

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators.

N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13.

12.

Antibodies against gonadotropin-releasing hormone (GnRH) in patients with diabetes mellitus is associated with lower body weight and autonomic neuropathy.

Berntorp K, Frid A, Alm R, Fredrikson GN, Sjöberg K, Ohlsson B.

BMC Res Notes. 2013 Aug 17;6:329. doi: 10.1186/1756-0500-6-329.

13.

[Patients with ischemic heart disease often suffers from diabetes].

Leósdóttir M, Grufman H, Frid A, Berntorp K, Tydén P.

Lakartidningen. 2013 May 29-Jun 4;110(22):1100-2. Swedish. No abstract available.

PMID:
23808082
14.

WISE recommendations to ensure the safety of injections in diabetes.

Strauss K; WISE Consensus Group.

Diabetes Metab. 2012 Jan;38 Suppl 1:S2-8. doi: 10.1016/S1262-3636(12)70975-8. Review.

PMID:
22305440
15.

Esophageal dysmotility is more common than gastroparesis in diabetes mellitus and is associated with retinopathy.

Gustafsson RJ, Littorin B, Berntorp K, Frid A, Thorsson O, Olsson R, Ekberg O, Ohlsson B.

Rev Diabet Stud. 2011 Summer;8(2):268-75. doi: 10.1900/RDS.2011.8.268. Epub 2011 Aug 10.

16.

Extreme lactic acidosis type B associated with metformin treatment.

Pikwer A, Vernersson E, Frid A, Sterner G.

NDT Plus. 2011 Dec;4(6):399-401. doi: 10.1093/ndtplus/sfr110. Epub 2011 Sep 14.

17.

Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: a randomized controlled trial.

Lewis EJ, Lewis JB, Greene T, Hunsicker LG, Berl T, Pohl MA, de Zeeuw D, Heerspink HL, Rohde RD, Atkins RC, Reutens AT, Packham DK, Raz I; Collaborative Study Group.

Am J Kidney Dis. 2011 Nov;58(5):729-36. doi: 10.1053/j.ajkd.2011.06.020. Epub 2011 Aug 26. Erratum in: Am J Kidney Dis. 2012 Feb;59(2):318.

PMID:
21872376
18.

[Fasting during Ramadan possible for some persons with diabetes--but not all. Increased risks with fasting during summer time--competent counseling is necessary].

Elgzyri T, Frid A.

Lakartidningen. 2011 Jul 20-Aug 9;108(29-31):1434-6. Review. Swedish. No abstract available.

PMID:
21853729
19.

Prevalence of impaired glucose tolerance and diabetes after gestational diabetes mellitus comparing different cut-off criteria for abnormal glucose tolerance during pregnancy.

Anderberg E, Landin-Olsson M, Kalén J, Frid A, Ursing D, Berntorp K.

Acta Obstet Gynecol Scand. 2011 Nov;90(11):1252-8. doi: 10.1111/j.1600-0412.2011.01214.x. Epub 2011 Aug 29.

PMID:
21679163
20.

Efficacy and safety of the PPARγ partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel-group study in patients with type 2 diabetes on stable insulin therapy.

Henriksen K, Byrjalsen I, Qvist P, Beck-Nielsen H, Hansen G, Riis BJ, Perrild H, Svendsen OL, Gram J, Karsdal MA, Christiansen C; BALLET Trial Investigators.

Diabetes Metab Res Rev. 2011 May;27(4):392-401. doi: 10.1002/dmrr.1187.

PMID:
21328517

Supplemental Content

Loading ...
Support Center